PM5-18065-31313
3 vaccinations
2 coded responses
9 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 201 / VA
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Dose 1 — Pfizer-BioNTech
-
2021-02-27
Registered in v-safe
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
-
2021-03-18
Dose 2 — Pfizer-BioNTech
-
2021-09-18
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-26
Dose 3 — Pfizer-BioNTech
- 2022-03-18
-
2022-05-28
Survey response — 3 months, dose 3MedDRA: Cough, Headache — Feeling: Good · Be unable to work or attend schoolFree text: Mild cough and headacheMedDRA releases: 2024-11 · check-in free text available
- 2023-02-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech | |
| 3 | 2022-02-26 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 11 — 3 months, dose 3
Symptoms: Mild cough and headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release